logo-loader
viewFeedback PLC

Feedback soars as Bleepa awarded place on NHSx National Clinical Communication Tool Framework

The medical imaging group said inclusion in the framework is a stamp of approval that will allow it to drive sales in other markets

Feedback PLC - Feedback soars as Bleepa awarded place on NHSx National Clinical Communication Tool Framework

Feedback PLC (LON:FDBK) shares soared in value on Thursday after saying its flagship imaging-based communication platform, Bleepa, has been awarded a place on the NHSx National Clinical Communication Tool (NCCT) framework.

The medical imaging specialist said the NCCT framework will provide a vehicle for NHS Trusts to buy Bleepa by drawing down from a £3mln centralised fund over two years, giving Bleepa national coverage and providing independent validation of the quality and suitability of the platform for frontline delivery, a stamp of approval that it said will allow it to drive sales in other markets.

WATCH: Feedback's Tom Oakley discusses plans for Bleepa rollout following £5.5mln raise

The framework will run for an initial period between August 3 2020 and August 3 2022 with a possible further extension for 12 months.

"Bleepa has set a new standard for medical communication tools. I am delighted Bleepa has been awarded a place on the NHSx Clinical Communication Tool framework which positions Bleepa in the vanguard of medical imaging communications and provides a vehicle for potential reimbursement whilst simultaneously making Bleepa available to the whole of the NHS", said Feedback chief executive Tom Oakley.

The company’s shares rocketed 82.2% to 2.05p in late-afternoon trading.

Quick facts: Feedback PLC

Price: 1.1125 GBX

LSE:FDBK
Market: LSE
Market Cap: £11.87 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Feedback's Tom Oakley says inclusion of Bleepa to major framework is big...

Feedback PLC's (LON:FDBK) Tom Oakley speaks to Proactive's Polly Middlehurst following the news its flagship imaging-based communication platform Bleepa has been awarded a place on the NHSx National Clinical Communication Tool (NCCT) framework. ''For Bleepa this isn't just a great opportunity...

2 weeks ago

2 min read